Briviact 75 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FJJ0G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,636
Award facts
- Contract value 100% obligated
- $12,635.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,635.85 on January 15, 2026, for the supply of Briviact 75 mg tablets (60-count units). This competitive, firm fixed-price award carries an ultimate completion date of January 16, 2026, and represents a non-set-aside procurement executed by the Defense Logistics Agency. The award is a child delivery order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.9 billion vehicle through December 2031 that serves as the primary pharmaceutical and medical supply procurement mechanism for military healthcare programs worldwide.
Briviact (brivaracetam) is an antiepileptic medication used to treat partial-onset seizures in military and veteran populations served by the Defense Health Agency and other federal healthcare systems. The DLA Medical Supply Chain routinely executes delivery orders under its prime vendor contracts to fulfill pharmaceutical requirements across therapeutic domains, ensuring timely availability of critical medications to military treatment facilities and healthcare institutions. AmerisourceBergen's demonstrated capability to compete successfully for such awards reflects its established role as a key vendor in the federal pharmaceutical procurement ecosystem.
Quick answers
Who was awarded contract SPE2DR26FJJ0G?
SPE2DR26FJJ0G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FJJ0G worth?
The government has obligated $12,636 on SPE2DR26FJJ0G.
Is contract SPE2DR26FJJ0G an order under another contract?
Yes. SPE2DR26FJJ0G is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJJ0G competed?
The extent of competition for SPE2DR26FJJ0G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award